Qualitative Study on Detection and Treatment of Non-Small Cell Lung Cancer in Patients With a History of Alcohol or Substance Use Disorder
Study explores barriers and facilitators for lung cancer care in patients with substance use history
Plain English Summary
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD is a Not Applicable clinical trial sponsored by University of Southern California studying Lung Non-Small Cell Carcinoma. This study looks at how a history of alcohol or substance use affects the detection and treatment of non-small cell lung cancer. It is for adults diagnosed with non-small cell lung cancer who have a history of alcohol or substance use disorder. Participation involves interviews to discuss experiences with cancer detection and treatment. There are no alternative treatments offered as part of this study; it is observational. The trial aims to enroll 45 participants.
Official Summary
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.
Who Can Participate
Here is what you need to know about eligibility for this trial. Adults aged 18 and older with a confirmed diagnosis of non-small cell lung cancer. Individuals who have received or are currently receiving treatment for their cancer. Must have a history of alcohol or substance use disorder (excluding tobacco) within the last 10 years, before their cancer diagnosis. Must be able to communicate in English or Spanish and provide informed consent. This trial is studying Lung Non-Small Cell Carcinoma, so participants generally need a confirmed diagnosis. The trial is currently accepting new participants.
What They're Measuring
The primary outcome of thematic saturation means researchers will continue interviews until no new significant information is being learned, ensuring a comprehensive understanding of patient experienc The specific primary outcome measures are: Thematic saturation (Up to 3 years). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial is important because it aims to uncover challenges that may prevent individuals with a history of substance use from receiving timely and effective lung cancer care, addressing a gap in und This research targets Lung Non-Small Cell Carcinoma, where improved treatment options are needed.
Investor Insight
This observational study by a university sponsor focuses on understanding patient experiences, indicating a need for better-tailored support services rather than a direct market opportunity for a new
Is This Trial Right for Me?
Ask your doctor about how your history might be considered in your cancer care plan. Participation involves sharing your experiences through interviews, which are expected to last 30-60 minutes. The study will take place over approximately three years, with interviews conducted at specific medical centers. This trial is currently recruiting participants. The trial is being conducted at 2 sites. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 45 participants
Interventions
- OTHER: Non-Interventional Study — Non-interventional study
Primary Outcomes
- Thematic saturation (Up to 3 years)
Full Eligibility Criteria
Inclusion Criteria: * \* Adults ≥ 18 years of age * Histopathologic or cytologic diagnosis of NSCLC * Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy) * History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis * Ability to understand and the willingness to sign a written informed consent * English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent Exclusion Criteria: * Patients with cognitive disability unable to maintain 30-60 minute conversation
Trial Locations
- Los Angeles General Medical Center, Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Frequently Asked Questions
What is clinical trial NCT07186699?
NCT07186699 is a Not Applicable OBSERVATIONAL study titled "Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD." It is currently recruiting and is sponsored by University of Southern California. The trial targets enrollment of 45 participants.
What conditions does NCT07186699 study?
This trial investigates treatments for Lung Non-Small Cell Carcinoma. The primary condition under study is Lung Non-Small Cell Carcinoma.
What treatments are being tested in NCT07186699?
The interventions being studied include: Non-Interventional Study (OTHER). Non-interventional study
What does Not Applicable mean for NCT07186699?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT07186699?
This trial is currently "Recruiting." It started on 2025-09-29. The estimated completion date is 2028-09-12.
Who is sponsoring NCT07186699?
NCT07186699 is sponsored by University of Southern California. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT07186699?
The trial aims to enroll 45 participants. The trial is currently recruiting and accepting new participants.
How is NCT07186699 designed?
This is a observational study.
What are the primary outcomes being measured in NCT07186699?
The primary outcome measures are: Thematic saturation (Up to 3 years). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT07186699 being conducted?
This trial is being conducted at 2 sites, including Los Angeles, California (United States).
Where can I find official information about NCT07186699?
The official record for NCT07186699 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07186699. This government database provides the most up-to-date and detailed information about the trial.
What is NCT07186699 testing in simple terms?
This study looks at how a history of alcohol or substance use affects the detection and treatment of non-small cell lung cancer. It is for adults diagnosed with non-small cell lung cancer who have a history of alcohol or substance use disorder.
Why is this trial significant?
This trial is important because it aims to uncover challenges that may prevent individuals with a history of substance use from receiving timely and effective lung cancer care, addressing a gap in und
What are the potential risks of participating in NCT07186699?
The main risk is the emotional impact of discussing personal health history and cancer experiences. Potential side effects are minimal as this is an interview-based study, but discomfort or distress during interviews is possible. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT07186699?
Ask your doctor about how your history might be considered in your cancer care plan. Participation involves sharing your experiences through interviews, which are expected to last 30-60 minutes. The study will take place over approximately three years, with interviews conducted at specific medical centers. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT07186699 signal from an investment perspective?
This observational study by a university sponsor focuses on understanding patient experiences, indicating a need for better-tailored support services rather than a direct market opportunity for a new This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participation involves interviews to discuss experiences with cancer detection and treatment. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Lung Non-Small Cell Carcinoma Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.